Superluminal Medicines

Superluminal Medicines is a generative biology and chemistry company that is developing a differentiated pipeline and revolutionizing the speed and accuracy of drug production. The company's platform leverages a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure to create candidate compounds at unprecedented speeds. The platform’s "Predict-Design-Test" architecture enables precise simulation of protein shapes and designs highly selective compounds targeting exact structural changes for therapeutic effects. Its discovery engine is powered by industry-leading computational pharmacokinetics and toxicology prediction capabilities.